Facioscapulohumeral Muscular Dystrophy PBMC for Research

Facioscapulohumeral Muscular Dystrophy PBMC products are sourced from donors clinically diagnosed with Facioscapulohumeral Muscular Dystrophy and processed under stringent conditions to support research. These cryopreserved peripheral blood mononuclear cells (PBMCs) enable studies related to FSHD-associated immune dysregulation, T cell response, and cytokine production.

Product Features

• Research Use Only (RUO), cryopreserved PBMCs
• Clinically confirmed FSHD donors
• Processed within 24 hours of collection
• Stored using CryoStore® CS10 freezing media
• IRB-approved protocols and electronic informed consent

Donor Metadata

• Verified FSHD diagnosis
• Donor demographics: age, sex assigned at birth, race/ethnicity
• Self-reported allergies and infectious disease history
• Additional fshd-specific data available upon request

Applications

• Biomarker discovery and validation
• Drug screening and therapeutic development
• Immune pathway analysis in Facioscapulohumeral Muscular Dystrophy (FSHD) pathophysiology
• Transcriptomic and proteomic profiling

Quality and Compliance

• IRB-approved collections and protocols
• 21 CFR Part 11 – compliant e-consent system
• HIPAA-compliant donor data protection

Ordering & Shipping

Facioscapulohumeral Muscular Dystrophy PBMC samples are shipped on dry ice and available in custom aliquots. For international orders or regulatory requirements, please contact to confirm documentation and compliance needs.